维普中文期刊产品整合服务
622篇 您的检索式:作者名="C Pai"
    题名 作者 年代 出处 被引量
1Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial显示文摘AIM: To investigate efficacy and safety of cetuximab combined with two chemotherapy regimens in patients with unresectable metastatic colorectal cancer (mCRC). METHODS: Randomized patients received cetuximab with 5-fluorouracil (5-FU), folinic acid (FA) and oxaliplatin (FOLFOX) 6 (arm A, n = 74) or 5-FU, FA and irinotecan (FOLFIRI) (arm B, n = 77). KRAS mutation status was determined retrospectively in a subset of tumors (n = 117). RESULTS: No significant difference was found between treatment arms A and B in the progression-free survival (PFS) rate at 9 mo, 45% vs 34%; median PFS, 8.6 mo vs 8.3 mo [hazard ratio (HR) = 1.06]; overall response rate (ORR) 43% vs 45% [odds ratio (OR) = 0.93] and median overall survival (OS), 17.4 mo vs 18.9 mo (HR = 0.98). Patients with KRAS wild-type tumors demonstrated improved PFS (HR = 0.55, P = 0.0051), OS, (HR = 0.62, P = 0.0296) and ORR (53% vs 36%) and in arm A, improved PFS (HR = 0.49, P = 0.0196), OS (HR = 0.48, P = 0.0201) and ORR (56%vs 30%), compared with patients with KRAS mutated tumors. In arm B no significant differences were found in efficacy by KRAS mutation status. Treatment in arms A and B was generally well tolerated. CONCLUSION: This study confirms that combinations of cetuximab with FOLFOX6 or FOLFIRI are effective and significantly improve clinical outcome in KRAS wild-type compared with KRAS mutated mCRC.Janja Ocvirk Thomas Brodowicz Fritz Wrba Tudor E Ciuleanu Galina Kurteva Semir Beslija Ivan Koza Zsuzsanna Pápai Diethelm Messinger Ugur Yilmaz Zsolt Faluhelyi Suayib Yalcin Demetris Papamichael Miklós Wenczl Zrinka Mrsic-Krmpotic Einat Shacham-Shmueli Damir Vrbanec Regina Esser Werner Scheithauer Christoph C Zie-linski 2010World Journal of Gastroenterology2010,16,25:17
2Monocyte chemoattractant protein-1, transforming growth factor-β1, nerve growth factor, resistin and hyaluronic acid as serum markers:comparison between recurrent acute and chronic pancreatitis显示文摘BACKGROUND: Diagnostic parameters that can predict the presence of chronic pancreatitis(CP) in patients with recurrent pain due to pancreatitis would help to direct appropriate therapy. This study aimed to compare the serum levels of monocyte chemoattractant protein-1(MCP-1), transforming growth factor-β1(TGF-β1), nerve growth factor(NGF), resistin and hyaluronic acid(HA) in patients with recurrent acute pancreatitis(RAP) and CP to assess their ability to differentiate the two conditions.METHODS: Levels of serum markers assessed by enzymelinked immunosorbent assay(ELISA) were prospectively compared in consecutive patients with RAP, CP and in controls and stepwise discriminant analysis was performed to identify the markers differentiating RAP from CP.RESULTS: One hundred and thirteen consecutive patients(RAP=32, CP=81) and 78 healthy controls were prospectively enrolled. The mean(SD) age of the patients was 32.0(14.0)years; 89(78.8%) were male. All markers were significantly higher in CP patients than in the controls(P<0.001); MCP-1NGF and HA were significantly higher in RAP patients than in the controls(P<0.001). Stepwise discriminant analysis showed significant difference(P=0.002) between RAP and CP for resistin with an accuracy of 61.9%, discriminant scores of ≤-0.479 and ≥0.189 indicating RAP and CP, respectively. The other markers had no differential value between RAP and CP.CONCLUSION: Serum resistin is a promising marker to differentiate between RAP and CP and needs validation in future studies, especially in those with early CP.M Ganesh Kamath C Ganesh Pai Asha Kamath Annamma Kurien 2016Hepatobiliary & Pancreatic Diseases International2016,15,2:7
3Definition of the Portuguese frameworks with international relevance as an input for the European geological heritage characterisation显示文摘J. Brilha C. Andrade A. Azeredo F.J.A.S. Barriga M. Cachāo2 H. Couto P.P. Cunha J.A. Crispim P. Dantas L. V. Duarte M. C Freitas H.M. Granja M.H. Henriques P. Henriques L. Lopes J. Madeira J.M.X. Matos F. Noronha J. Pais J. Pifarra M.M. Ramalho J.M.R.S. Relvas A. Ribeiro A. Santos V.F.Santos P. Terrinha 2005Episodes2005,28,3:5
4Continuing episodes of pain in recurrent acute pancreatitis: Prospective follow up on a standardised protocol with drugs and pancreatic endotherapy显示文摘AIM To assess the outcomes of drug therapy(DT)followed by pancreatic endotherapy for continuing painful episodes in recurrent acute pancreatitis.METHODS DT comprised of pancreatic enzymes and antioxidants failing which,endotherapy(ET;pancreatic sphincterotomy and stent placement)was done.The frequency of pain,its visual analogue score(VAS),quality of life(Qo L),serum C peptide and faecal elastase were compared between baseline and after 1 year of follow up in all patients and in the two subgroups on DT and ET.Response was defined as at least 50%reduction in the severity of pain to below a score of 5.RESULTS Of the thirty nine patients analysed,21(53.9%)responded to DT and 18(46.1%)underwent ET.The VAS for pain(7.0±2.0 vs 1.3±2.5,P<0.001)and the number of days with pain per month decreased[1.0(1.0,2.0)vs 1.0(0.0,1.0),P<0.001],and the Qo L scores[55.0(44.0,66.0)vs 38.0(32.00,51.00),P<0.01]improved significantly during follow up.Similar significant improvements were seen in patients in the subgroups of DT and ET except for Qo L in ET.The serum C-peptide(P=0.001)and FE(P<0.001)levels improved significantly in the entire group and in the two subgroups of patients except for the C peptide levels in patients on DT.CONCLUSION A standardised protocol of DT,followed by ET decreased the intensity and frequency of pain in recurrent acute pancreatitis,enhanced Qo L and improved pancreatic function.C Ganesh Pai M Ganesh Kamath Mamatha V Shetty Annamma Kurien 2017World Journal of Gastroenterology2017,23,19:2
5Defining acute-on-chronic liver failure: East,West or Middle ground?显示文摘Acute-on-chronic liver failure(ACLF),a newly recognized clinical entity seen in hospitalized patients with chronic liver disease including cirrhosis,is associated with high short- and medium term morbidity and mortality.Noneof the definitions of ACLF proposed so far have been universally accepted,the two most commonly used being those proposed by the Asia-Pacific Association for the Study of Liver(APASL) and the European Association for the Study of Liver- Chronic Liver Failure(EASL-CLIF) consortium.On paper both definitions and diagnostic criteria appear to be different from each other,reflecting the differences in cut-off values for individual parameters used in diagnosis,the acute insult or precipitating event and the underlying chronic liver disease.Data directly comparing these two criteria are limited,and available studies reveal different outcomes when the two are applied to the same set of patients.However a review of the literature suggests that both definitions do not seem to identify the same set of patients.The definition given by the APASL consortium is easier to apply in day-to-day practice but the EASLCLIF criteria appear to better predict mortality in ACLF.The World Gastroenterology Organization working party have proposed a working definition of ACLF which will identify patients from whom relevant data can be collected so that the similarities and the differences between the two regions,if any,can be clearly defined.Harneet Singh C Ganesh Pai 2015World Journal of Hepatology2015,7,25:2
6Improving hierarchical cluster analysis: a new method with outlier detection and automatic clustering显示文摘ALMEIDA J A S BARBOSA L M S PAIS A A C C 2007Chemometrics and Intelligent Labora- tory Systems2007,87,2:1
7Prediction of asphalt pavement temperature using 3-D finite element method显示文摘Minhoto Manuel J C Pais Jorge C Pereira Paulo A 2005Transportation Research Record2005,1919,184:1
8Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation显示文摘Pai R Lin C Tran T 2005Biochem Biophys Res Commun2005,331,:1
9Surface roughness and its effects on the heat transfer mechanism in spray cooling 显示文摘Pais M R Chow L C Mathefdey E T 1992ASME Journal of Heat Transfer1992,114,1:1
10Probabilistic assessment of regional mercury exposure显示文摘Seigneur C Pai P Gerath M 1997Water air and soil pollution1997,97,:1
11Iberian Universities: a Characterisation from ESI Ranldngs显示文摘Cova T F G G Pais A A C C Formosinho S O J 2013Scientomet- tics2013,94,3:1
12Nanosecond repetitively pulsed discharges in air at atmospheric pressure—the spark regime显示文摘Pai D Z Lacoste D A Laux C O 2010Plasma Sources Science and Technology2010,19,06:1
13Pedunculated cribriform adenocarcinoma of the base of the tongue显示文摘Prasad K C Kaniyur V Pai R R 2004Ear Nose Throat J2004,83,1:1
14Do miniserews remain stationary under orthod ontic forces显示文摘Liou E J Pai B C Lin J C 2004Am J Orthod Dentofacial Orthop2004,126,1:1
15Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI显示文摘Chin C L Tovcimak A E Hradil V P Seifert T R Hollingsworth P R Chandran P Zhu C Z Gauvin D Pai M Wetter J Hsieh G C Honore P Frost J M Dart M J Meyer M D Yao B B Cox B F Fox G B 0,,02:1
16Microstructure and mechanical properties of Si and Sb added AZ91 magnesium alloy显示文摘SRINIVASAN A PILLAI U T S PAI B C 2005Metallurgical and Materials Transactions A2005,36,8:1
17Effects acidity and molybdate concentration on the kinetics of the formation of the phosphoantimonylmolybdenum blue complex显示文摘PAI S C YANG C C RILEY J P 1990Analytica Chimica1990,229,:1
18Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma显示文摘Ward C Pais M Bish R 2002Thorax2002,57,4:1
19Relationships between Voltage and Angle Stability of Power Systems显示文摘Voumas C D Sauer P W Pai M A 1996International Journal of Electrical Power and Energy System1996,,:1
20Isolation of bacteria with antibiotic resistance from household cockroaches (Periplaneta americana and Blattella germanica)显示文摘PAI H H CHEN W C PENG C F 2005Acta Trop2005,93,3:1
返回顶部 每页显示:
共32页 首页 上一页 第1页 下一页 末页 /32 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费